Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics for ₹429.37 crore
3 days, 21 hours ago

Fortis Healthcare acquires 7.61% stake in Agilus Diagnostics for ₹429.37 crore

Live Mint  

Fortis Healthcare Ltd announced the acquisition of 5,970,149 equity shares from the International Finance Corporation, representing a 7.61 per cent stake in its material subsidiary, Agilus Diagnostics Ltd. "The company on December 20, 2024, at 07:18 PM has acquired 5,970,149 equity shares as held by International Finance Corporation in Agilus Diagnostics Limited from IFC," said Fortis Healthcare in a regulatory filing to the stock exchanges. Fortis Healthcare acquires stake in Agilus Diagnostics The acquisition forms part of a broader plan wherein Fortis Healthcare will acquire a total of 31.52 per cent equity in Agilus. “The company shall also acquire equity stake held by NYLIM Jacob Ballas India Fund III LLC and Resurgence PE Investments Ltd," said Fortis Healthcare.

History of this topic

Fortis Healthcare Q4: Net profit up 59% to ₹138.3 cr, dividend declared
1 year, 7 months ago

Discover Related